Market News & Trends
Atossa Genetics Preliminary Phase 2 Study Achieves Primary Endpoint
Atossa Genetics Inc. recently announced that a preliminary analysis from its recently completed Phase 2 study of the company’s proprietary 20-mg daily topical Z Endoxifen…
Novavax Confirms Accelerated Approval Pathway Available for Licensure of NanoFlu
Novavax, Inc. recently announced it will utilize the accelerated approval pathway for licensure for NanoFlu, its nanoparticle seasonal influenza vaccine candidate. The US FDA acknowledged…
Innate Pharma Announces Publication of Phase I Clinical Trial Results
Innate Pharma SA recently announced the online publication in The Lancet Oncology of the results from the completed Phase 1 dose-escalation and expansion clinical trial…
Cara Therapeutics Announces Initiation of Phase 2 Trial of Oral KORSUVA
Cara Therapeutics, Inc. recently announced the initiation of a Phase 2 trial of Oral KORSUVA (CR845/difelikefalin) for the treatment of pruritus in patients with hepatic…
Theralase Announces Health Canada Approves Amended Clinical Trial Application
Theralase Technologies Inc. recently announced that Health Canada has issued a No Objection Letter (NOL) for an amended Clinical Trial Application (CTA) for its Phase…
Predictive Oncology Subsidiary, Helomics, Signs Collaborative Research Agreement With ChemImage
Predictive Oncology recently announced it has signed a collaborative research agreement with molecular imaging company, ChemImage, to establish the feasibility of coupling genomics to Raman…
Aptinyx Presents Preclinical Data Demonstrating Robust Activity of NYX-783
Aptinyx Inc. recently announced the presentation of preclinical data on its novel NMDA receptor modulator, NYX-783, demonstrating that the product candidate robustly attenuated alcohol-seeking and…
Ziopharm Oncology Completes Enrollment of Phase 1 Combination Trial
Ziopharm Oncology, Inc. recently announced completion of enrollment of the third cohort of a Phase 1 clinical trial evaluating Controlled IL-12 (Ad-RTS-hIL-12 plus veledimex, Ad+V),…
Janssen Announces Collaboration to Expand Data Science Research in Healthcare
Janssen Research & Development, LLC, part of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), recently announced a collaboration with the University of California,…
Double Chamber Prefilled Syringes Market Likely to be Driven by Growing Requirement of Highly Efficient Parental Drug Delivery Modes
A new study on Double Chamber Prefilled Syringes, opines global double chamber prefilled syringes market to grow at a CAGR of 9% during the forecast period. Over…